Pancreatic Cancer
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography is useful in diagnosing, staging, and assessing resectability and metabolic response in pancreatic cancer. This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in pancreatic cancer.